DOSE-DEPENDENT INTESTINAL-ABSORPTION AND SIGNIFICANT INTESTINAL EXCRETION (EXSORPTION) OF THE BETA-BLOCKER PAFENOLOL IN THE RAT

Citation
H. Lennernas et Cg. Regardh, DOSE-DEPENDENT INTESTINAL-ABSORPTION AND SIGNIFICANT INTESTINAL EXCRETION (EXSORPTION) OF THE BETA-BLOCKER PAFENOLOL IN THE RAT, Pharmaceutical research, 10(5), 1993, pp. 727-731
Citations number
18
Categorie Soggetti
Pharmacology & Pharmacy",Chemistry
Journal title
ISSN journal
07248741
Volume
10
Issue
5
Year of publication
1993
Pages
727 - 731
Database
ISI
SICI code
0724-8741(1993)10:5<727:DIASIE>2.0.ZU;2-O
Abstract
The elimination of [H-3]pafenolol and metabolites was investigated in fasted and fed rats. Separate groups received intravenous doses (0.3 a nd 3.0 mumol/kg) and oral doses (1 and 25 mumol/kg). After iv administ ration of pafenolol, the excretion of unchanged drug into urine and fe ces was about 50 and 25-30% of the given dose, respectively. The predo minating mechanism for the excretion of pafenolol into feces was intes tinal excretion (exsorption) directly from blood into gut lumen, since only about 3% of a given iv dose was recovered as pafenolol in the bi le. When the oral dose was raised from 1 to 25 mumol/kg, the mean (+/- SD) bioavailability, calculated from urine data, increased from 14 +/- 9 to 30 +/- 11% (P < 0.05) in the starved rats and from 14 +/- 3 to 1 6 +/- 3% in the fed animals. In parallel, the fraction absorbed from t he gut (f(a)) increased from 19 +/- 9 to 31 +/- 10% in the starved rat s and from 16 +/- 4 to 19 +/- 5% in the fed animals, respectively. Thi s indicates that the low bioavailability is due primarily to poor inte stinal uptake.